The Chinese Society for Immunology (CSI), a voluntary, national, academic, non-profit and non-governmental organization, formed from the national scientific and technical immunologists, is registered and established in accordance with the laws of China. CSI has grown out of the Chinese Committee for Immunology, which was founded in 1984, and became a member of the International Union of Immunological Societies (IUIS) in the same year. The formal proceedings to establish CSI began in 1988 after it was approved and affiliated with the China Association for Science and Technology. In 1992, CSI became a member of The Federation of Immunological Societies of Asia-Oceania (FIMSA). Currently, the society possesses over 10000 members and 3500 members belong to the IUIS.

Yuzhang Wu, MD, PhD

Xuetao Cao, MD, PhD

Official Journal of CSI

International Meetings of Interest

The 9th International γδ T cell Conference
(June 18 - 21, 2021, Beijing, China)


Prof. Erwei Song and Shicheng Su’s Group reveals a novel strategy for promoting T cell trafficking to tumors

Summary of the 2nd CSI Advanced Course of Cancer Immunotherapy

Prof. Beicheng Sun’s and Anning Lin’s team unveils a novel inflammation-cancer transformation mechanism in Hepatocellular carcinoma

Prof. Bing Su's group reveals a new type of intestinal stromal cells and its role in repairing damaged intestine

Prof. Zhengfan Jiang’s group reveals that sulfated glycosaminoglycans are coligands for STING activation

Yichuan Xiao's and Mingyue Zheng’s group reveals a new DNA-sensing pathway in CD4+ T cells and its regulatory mechanism in mediating aging-related autoimmune disease

Dr. Hai Qi’s team reveals a novel mechanism that promotes high-affinity antibody selection

Prof. Zhigang Tian’s group reveals extramedullary development of innate lymphoid cells

Dr. Xindong Liu’s team provides SOSTDC1-producing follicular helper T cells promote regulatory follicular T cell differentiation

Dr. Yuxia Zhang’s team provides comprehensive liver immune profiling in infants with biliary atresia and proposes B-cell-modifying therapies to alleviate liver pathology

Dr. Xuetao Cao’s group identifies a novel lncRNA which promotes antiviral innate immunity

The Investigation of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity by NIFDC researchers published in Cell

WANG Honglin’s group revealed the presence of "autoantigens" in the epidermal keratinocytes of patients with psoriasis and provided a new treatment strategy

Dr. Chenqi Xu’s group developed a new strategy of CAR-T cell therapy

Dr. Haopeng Wang’s group at ShanghaiTech University developed a novel CAR-T therapy